Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Masked, Multicenter Study to Assess the Safety and Efficacy of CLS-TA, Triamcinolone Acetonide Injectable Suspension in the Treatment of Subjects With Macular Edema Following Uveitis

Trial Profile

A Randomized, Masked, Multicenter Study to Assess the Safety and Efficacy of CLS-TA, Triamcinolone Acetonide Injectable Suspension in the Treatment of Subjects With Macular Edema Following Uveitis

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 01 May 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Triamcinolone (Primary)
  • Indications Retinal oedema; Uveitis
  • Focus Therapeutic Use
  • Acronyms DOGWOOD
  • Sponsors Clearside Biomedical
  • Most Recent Events

    • 01 May 2019 According to a Clearside Biomedical media release, pooled results from this and other two trials (PEACHTR and AZALEA) were presented at the merican Uveitis Society Spring Meeting 2019.
    • 19 Feb 2019 According to a Clearside Biomedical media release, a combined analysis on the results from the AZALEA, DOGWOOD, and PEACHTREE studies was presented at the 42nd Annual Macula Society Meeting held February 13-16, 2019 in Bonita Springs, Florida.
    • 09 Nov 2016 According to a Clearside Biomedical media release, data from the study has been presented at the American Society of Retina Specialists annual meeting in August 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top